CD68 positive and/or CD163 positive tumor-associated macrophages and PD-L1 expression in breast phyllodes tumor

Anderson B, Lawton T, Lehman C, Moe R (2004) Phyllodes tumor. In: Morrow M, Osborne C (eds) Disease of the breast. Lippincott & Wilkins, Philadelphia, pp 991–1006

WHO Classification of Tumours Editorial Board (2019) World Heath Organization Classification of Tumors, 5th. IARC Press, Lyon

World Health Organization., International Agency for Research on Cancer (2020) WHO classification of tumours of breast, 5th edn. IARC Press, Lyon

Lenhard MS, Kahlert S, Himsl I et al (2008) Phyllodes tumour of the breast: clinical follow-up of 33 cases of this rare disease. Eur J Obstet Gynecol Reprod Biol 138(2):217–221. https://doi.org/10.1016/j.ejogrb.2007.08.002

Article PubMed Google Scholar

Karim RZ, Gerega SK, Yang YH et al (2009) Phyllodes tumours of the breast: a clinicopathological analysis of 65 cases from a single institution. Breast 18(3):165–170. https://doi.org/10.1016/j.breast.2009.03.001

Article CAS PubMed Google Scholar

Tan PH, Thike AA, Tan WJ et al (2012) Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol 65(1):69–76. https://doi.org/10.1136/jclinpath-2011-200368

Article PubMed Google Scholar

Dong H, Strome SE, Salomao DR et al (2002) Tumor-associated B7–H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8(8):793–800. https://doi.org/10.1038/nm730

Article CAS PubMed Google Scholar

Brown JA, Dorfman DM, Ma FR et al (2003) Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol 170(3):1257–1266

Article CAS PubMed Google Scholar

Weber JS, Kudchadkar RR, Yu B et al (2013) Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma. J Clin Oncol 31(34):4311–4318. https://doi.org/10.1200/jco.2013.51.4802

Article CAS PubMed PubMed Central Google Scholar

Tumeh PC, Harview CL, Yearley JH et al (2014) PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515(7528):568–571. https://doi.org/10.1038/nature13954

Article CAS PubMed PubMed Central Google Scholar

Herbst RS, Soria JC, Kowanetz M et al (2014) Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature 515(7528):563–567. https://doi.org/10.1038/nature14011

Article CAS PubMed PubMed Central Google Scholar

Powles T, Eder JP, Fine GD et al (2014) MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer. Nature 515(7528):558–562. https://doi.org/10.1038/nature13904

Article CAS PubMed Google Scholar

Chauhan A, Siegel L, Freese R et al (2021) Performance of Ventana SP263 PD-L1 assay in endobronchial ultrasound guided-fine-needle aspiration derived non-small-cell lung carcinoma samples. Diagn Cytopathol 49(3):355–362. https://doi.org/10.1002/dc.24654

Article PubMed Google Scholar

Ai L, Xu A, Xu J (2020) Roles of PD-1/PD-L1 pathway: signaling, cancer, and beyond. Adv Exp Med Biol 1248:33–59. https://doi.org/10.1007/978-981-15-3266-5_3

Article CAS PubMed Google Scholar

Yi M, Zheng X, Niu M et al (2022) Combination strategies with PD-1/PD-L1 blockade: current advances and future directions. Mol Cancer 21(1):28. https://doi.org/10.1186/s12943-021-01489-2

Article CAS PubMed PubMed Central Google Scholar

Martinez FO, Sica A, Mantovani A, Locati M (2008) Macrophage activation and polarization. Front Biosci 13:453–461

Article CAS PubMed Google Scholar

Cassetta L, Cassol E, Poli G (2011) Macrophage polarization in health and disease. Sci World J 11:2391–2402. https://doi.org/10.1100/2011/213962

Article CAS Google Scholar

Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4(1):71–78. https://doi.org/10.1038/nrc1256

Article CAS PubMed Google Scholar

Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12):958–969. https://doi.org/10.1038/nri2448

Article CAS PubMed PubMed Central Google Scholar

Li W, Wu F, Zhao S et al (2022) Correlation between PD-1/PD-L1 expression and polarization in tumor-associated macrophages: a key player in tumor immunotherapy. Cytokine Growth Factor Rev 67:49–57. https://doi.org/10.1016/j.cytogfr.2022.07.004

Article CAS PubMed Google Scholar

Pu Y, Ji Q (2022) Tumor-associated macrophages regulate PD-1/PD-L1 immunosuppression. Front Immunol 13:874589. https://doi.org/10.3389/fimmu.2022.874589

Article CAS PubMed PubMed Central Google Scholar

Giunchi F, Gevaert T, Scarpelli M, Fiorentino M (2020) Status of Programmed Death Ligand 1 (PD-L1) by Immunohistochemistry and Scoring Algorithms. Curr Drug Targets 21(13):1286–1292. https://doi.org/10.2174/1389450121666200123124642

Article CAS PubMed Google Scholar

Cassidy M, Loftus B, Whelan A et al (1994) KP-1: not a specific marker Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes. Virchows Arch 424(6):635–640. https://doi.org/10.1007/bf00195778

Article CAS PubMed Google Scholar

Loftus B, Loh LC, Curran B et al (1991) Mac387: its non-specificity as a tumour marker or marker of histiocytes. Histopathology 19(3):251–255. https://doi.org/10.1111/j.1365-2559.1991.tb00030.x

Article CAS PubMed Google Scholar

Shabo I, Stål O, Olsson H et al (2008) Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int J Cancer 123(4):780–786. https://doi.org/10.1002/ijc.23527

Article CAS PubMed Google Scholar

Shabo I, Olsson H, Sun XF, Svanvik J (2009) Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time. Int J Cancer 125(8):1826–1831. https://doi.org/10.1002/ijc.24506

Article CAS PubMed Google Scholar

Valadi H, Ekström K, Bossios A et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654–659. https://doi.org/10.1038/ncb1596

Article CAS PubMed Google Scholar

Shabo I, Svanvik J (2011) Expression of macrophage antigens by tumor cells. Adv Exp Med Biol 714:141–150. https://doi.org/10.1007/978-94-007-0782-5_7

Article CAS PubMed Google Scholar

Vignery A (2005) Macrophage fusion: the making of osteoclasts and giant cells. J Exp Med 202(3):337–340. https://doi.org/10.1084/jem.20051123

Article CAS PubMed PubMed Central Google Scholar

Shabo I, Midtbö K, Andersson H et al (2015) Macrophage traits in cancer cells are induced by macrophage-cancer cell fusion and cannot be explained by cellular interaction. BMC Cancer 15:922. https://doi.org/10.1186/s12885-015-1935-0

View original article

BREAST CANCER RESEARCH AND TREATMENT

0 0 0 0 0 0 0

留言 (0)